John Wills
Internal Medicine · Dallas, TXNPI 1811915895
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.7% of the total across 97 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by Novo Nordisk at 27.4% of the total. Reporting peaked in 2020 at $763 and has fallen 97.4% since, to $20 in 2024.
Across 97 payments — averaging $16.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$427
- AbbVie$144
- Amarin Pharma, Inc.$129
- Lilly USA, LLC$96
- Pfizer$88
- AstraZeneca$70
- plus $603 from 18 others
What the payments were for
- Food & beverage$1,52298%
- Education$362%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 30 | $427 |
| AbbVie(2 entities) | 8 | $144 |
| Amarin Pharma, Inc. | 6 | $129 |
| Lilly USA, LLC | 7 | $96 |
| Pfizer | 4 | $88 |
| AstraZeneca | 5 | $70 |
| Esperion Therapeutics, Inc. | 4 | $69 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $69 |
| Merck | 5 | $61 |
| Currax Pharmaceuticals LLC | 5 | $59 |
| Boehringer Ingelheim | 3 | $47 |
| Arbor Pharmaceuticals, Inc. | 3 | $44 |
| GSK | 2 | $38 |
| Coloplast | 1 | $36 |
| Amneal Pharmaceuticals LLC | 1 | $28 |
| CMP Pharma, Inc. | 1 | $21 |
| Jazz Pharmaceuticals Inc. | 1 | $21 |
| Bausch Health US, LLC | 1 | $18 |
| IBSA Pharma Inc. | 1 | $18 |
| Abbott | 1 | $17 |
| Ironshore Pharmaceuticals Inc. | 1 | $16 |
| Astellas Pharma US Inc | 1 | $15 |
| Antares Pharma, Inc. | 1 | $15 |
| Eisai Inc. | 1 | $14 |
How this compares
$1,557 in reported general payments places this provider in the 75th percentile of 7,675 internal medicine providers in Texas.
Other internal medicine in Dallas
- Marc TribbleDallas$693K
- Gary SinclairDallas$599K
- Han SchmidlyDallas$465K
- Athica VatanapradithDallas$164K
- Nicholaos BellosDallas$113K
- Steven HeldDallas$65K
- Amit VermaDallas$53K
- Spencer BerthelsenSugar Land$891K
- Hameed AliTemple$773K
- Mohammed Al-NajjarEl Paso$586K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.